High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study

被引：14
|
作者：
Guida, Michele [1 ]
Cramarossa, Antonio [2 ]
Fistola, Ettore [1 ]
Porcelli, Mariangela [1 ]
Giudice, Giuseppe [3 ]
Lubello, Katia [1 ]
Colucci, Giuseppe [1 ]
机构：
[1] Natl Canc Inst, Dept Med Oncol, Bari, Italy
[2] Natl Canc Inst, Dept Radiol, Bari, Italy
[3] Natl Canc Inst, Dept Plast & Reconstruct Surg, Bari, Italy
来源：
JOURNAL OF TRANSLATIONAL MEDICINE | 2010年 / 8卷
关键词：
DISSEMINATED MALIGNANT-MELANOMA; PHASE-III; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; GLIOBLASTOMA PATIENTS; CEREBRAL METASTASES; ALKYLATING-AGENTS; ONCOLOGY-GROUP; DACARBAZINE; MGMT; CHEMOTHERAPY;
D O I：
10.1186/1479-5876-8-115
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页数：8
相关论文
共 38 条
  • [1] High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study
    Michele Guida
    Antonio Cramarossa
    Ettore Fistola
    Mariangela Porcelli
    Giuseppe Giudice
    Katia Lubello
    Giuseppe Colucci
    [J]. Journal of Translational Medicine, 8
  • [2] HIGH ACTIVITY OF SEQUENTIAL COMBINATION OF LOW DOSE CHEMO-MODULATING TEMOZOLOMIDE (TMZ) plus FOTEMUSTINE (FM) IN METASTATIC MELANOMA (MM). A FEASIBILITY STUDY
    Guida, M.
    Cramarossa, A.
    Fistola, E.
    Porcelli, M.
    Lubello, K.
    Misino, A.
    Colucci, G.
    [J]. CANCER TREATMENT REVIEWS, 2010, 36 : S104 - S104
  • [3] SEQUENTIAL COMBINATION OF LOW DOSE CHEMO-MODULATING TEMOZOLOMIDE WITH FOTEMUSTINE IN METASTATIC MELANOMA (MM). A PHASE II STUDY
    Guida, M.
    Cramarossa, A.
    Petrillo, P.
    Albano, A.
    Pisconti, S.
    Aieta, M.
    Traversa, M.
    Ridolfi, R.
    Colucci, G.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 370 - 370
  • [4] Sequential combination of low dose chemo-modulating Temozolomide and Fotemustine in metastatic melanoma: clinical and molecular evaluation
    De Summa, S.
    Pinto, R.
    Strippoli, S.
    Natalicchio, I.
    Azzariti, A.
    Cramarossa, A.
    Signorile, M.
    Albano, A.
    Lorusso, V.
    Guida, G.
    Guida, M.
    Tommasi, S.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 26 - 27
  • [5] Phase II study of the frontline combination of ipilimumab and temozolomide in patients with metastatic melanoma.
    Patel, Sapna Pradyuman
    Hwu, Wen-Jen
    Kim, Kevin B.
    Papadopoulos, Nicholas E.
    Hwu, Patrick
    Radvanyi, Laszlo George
    Mahoney, Sandy
    Deburr, Tawania L.
    Liu, Ping
    Bedikian, Agop Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
    Michele Guida
    Stefania Tommasi
    Sabino Strippoli
    Maria Iole Natalicchio
    Simona De Summa
    Rosamaria Pinto
    Antonio Cramarossa
    Anna Albano
    Salvatore Pisconti
    Michele Aieta
    Ruggiero Ridolfi
    Amalia Azzariti
    Gabriella Guida
    Vito Lorusso
    Giusepe Colucci
    [J]. BMC Cancer, 18
  • [7] The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
    Guida, Michele
    Tommasi, Stefania
    Strippoli, Sabino
    Natalicchio, Maria Iole
    De Summa, Simona
    Pinto, Rosamaria
    Cramarossa, Antonio
    Albano, Anna
    Pisconti, Salvatore
    Aieta, Michele
    Ridolfi, Ruggiero
    Azzariti, Amalia
    Guida, Gabriella
    Lorusso, Vito
    Colucci, Giusepe
    [J]. BMC CANCER, 2018, 18
  • [8] A Phase I Study of High-Dose Calcitriol in Combination with Temozolomide for Patients with Metastatic Melanoma
    Pettijohn, Erin
    Martone, Brenda
    Rademaker, Alfred
    Kuzel, Timothy
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2014, 4 (04) : 448 - 458
  • [9] Phase II trial of sequential temozolomide (TMZ) and high-dose bolus (HDB) IL-2 in patients with metastatic melanoma.
    Agarwala, S. S.
    Tarhini, A. A.
    Kirkwood, J. M.
    Cai, C.
    Stover, L.
    Moschos, S.
    Gooding, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 462S - 462S
  • [10] Sequential administration of high-dose interleukin-2 and ipilimumab in patients with metastatic melanoma.
    Patel, Sapna Pradyuman
    Milton, Denai
    Milhem, Mohammed M.
    Flaherty, Lawrence E.
    Hallmeyer, Sigrun
    Feun, Lynn G.
    Hauke, Ralph J.
    Cranmer, Lee D.
    Daniels, Gregory A.
    Doolittle, Gary C.
    Taback, Bret
    Morse, Michael
    Lutzky, Jose
    Sharfman, William Howard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
1234